Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 12,024.00
Ask: 12,026.00
Change: 36.00 (0.30%)
Spread: 2.00 (0.017%)
Open: 12,254.00
High: 12,256.00
Low: 12,018.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK rolls out AstraZeneca vaccine, touts British science triumph

Mon, 04th Jan 2021 07:57

* UK first to roll out AstraZeneca

* UK has vaccinated 1 million people

* Oxford/AstraZeneca shot can be stored in fridge

* China and Russia vaccinate their populations
(Adds first patient to get the vaccine)

By William James and Guy Faulconbridge

LONDON, Jan 4 (Reuters) - Britain began vaccinating its
population on Monday with the COVID-19 shot developed by Oxford
University and AstraZeneca, touting its position as the
first Western country to roll out an inoculation programme
against the novel coronavirus.

Britain, which is rushing to vaccinate its population faster
than the United States and the rest of Europe in a bid to put
the pandemic behind it, is the first country to roll out the
Oxford/AstraZeneca shot.

It last year rolled out the Pfizer and Germany's
BioNTech vaccine. Dialysis patient Brian Pinker, 82, was the
first to get the Oxford/AstraZeneca shot at 0730 GMT at Oxford
University Hospital.

"I am so pleased to be getting the COVID vaccine today and
really proud that it is one that was invented in Oxford,"
Pinker, a retired maintenance manager who has been having
dialysis for kidney disease, said.

He said he was looking forward to celebrating his 48th
wedding anniversary with wife Shirley in February.

"The nurses, doctors and staff today have all been
brilliant," he said.

Britain has put more than 1 million COVID-19 vaccines into
arms already - more than the rest of Europe put together, Health
Secretary Matt Hancock said, adding that the roll out of the
Oxford/AstraZeneca vaccine was a triumph.

"That's a triumph of British science that we've managed to
get where we are," Hancock told Sky. "Right at the start, we saw
that the vaccine was the only way out long term."

Prime Minister Boris Johnson’s government has secured 100
million doses of the Oxford/AstraZeneca vaccine which can be
stored at fridge temperatures between two to eight degrees,
making it easier to distribute than the Pfizer shot.

Six hospitals in England are administering the first of
around 530,000 doses Britain has ready. The programme will be
expanded to hundreds of other British sites in the coming days,
and the government hopes it will deliver tens of millions of
doses within months.
(Writing by William James and Guy Faulconbridge; Editing by
Susan Fenton, Kate Holton and Raissa Kasolowsky)

More News
Today 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
Today 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
Today 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
Today 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.